Your search returned 52 studies. (Get alerts for new studies):
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL - Untreated - Front-line - First-Line - Initial Therapy
4 Locations available
- Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms - Colorectal or Kidney Neoplasms - Pancreatic Neoplasms - Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive - Melanoma - CLL
1 Location available
- Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell
1 Location available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic -
4 Locations available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Conditions: CLL - Leukemia
1 Location available
- Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
2 Locations available
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Conditions: B-cell Chronic Lymphocytic Leukemia - Hematopoietic/Lymphoid Cancer - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia
1 Location available
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - B Chronic Lymphocytic Leukemia
2 Locations available
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Leukemia
1 Location available
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Tri
Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL)
23 Locations available
- A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients
Conditions: Small Lymphocytic Lymphoma - CLL (Chronic Lymphocytic Leukemia)
1 Location available
- Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL
Conditions: Chronic Lymphocytic Lymphoma
1 Location available
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CON
Conditions: B-cell Chronic Lymphocytic Leukemia
21 Locations available
- Fludarabine, Bendamustine, and Rituximab (FBR) in Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia
1 Location available
- Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
10 Locations available
- Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL)
7 Locations available
- Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: CLL
2 Locations available
- Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Conditions: Leukemia - Lymphoma
1 Location available
- Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Conditions: Leukemia
1 Location available
- Phase II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma - Leukemia, Prolymphocytic
1 Location available
- Collection of Tissue Samples for Study of Multidrug Resistance
Conditions: Cllinical Drug Resistance - Cancer
1 Location available
- Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Advanced Cancers - Leukemia
1 Location available
- Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
Conditions: CLL - SLL
1 Location available
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
Conditions: Chronic Lymphocytic Leukemia (CLL)
2 Locations available
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
Conditions: Chronic Lymphocytic Leukemia
6 Locations available
- Clinical Trial of L-Grb-2 Antisense Oligonucleotide in CML, AML, ALL & MDS
Conditions: Safety and Pharmacokinetics of L-Grb-2 in Treating CML, AML, CLL and MDS
1 Location available
- Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic L
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma (SLL)
1 Location available
- PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Leukemia, Lymphocytyc - CLL (Chronic Lymphocytic Leukemia) - SLL (Small Lymphocytic Lymphoma)
1 Location available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
Conditions: Leukaemia, Lymphocytic, Chronic
3 Locations available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Conditions: Hematologic Malignancy - Leukemia - Acute Lymphoblastic Leukemia - ALL - Acute Myelogenous Leukemia - AML - Chronic Lymphocytic Leukemia - CLL - Lymphoma - Hodgkin's Lymphoma - Non-hodgkin's Lymphoma - Myeloma
1 Location available
- Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma
Conditions: Acute Lymphocytic Leukemia - Follicular Lymphoma - Chronic Lymphocytic Leukemia (CLL) - Mantle Cell Lymphoma - Prolymphocytic Leukemia - Large Cell Lymphoma
1 Location available
- Omega 3 Supplementation for the Prevention of Disease Progression in Early Stage Chronic Lymphocytic Leukemia (ES-CLL), Monoclonal Gammopathy of Undet
Conditions: Chronic Lymphocytic Leukemia (CLL Enrollment Maximum Has Been Met) - Monoclonal Gammopathy of Undetermined Significance - Smoldering Multiple Myeloma
1 Location available
- A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Conditions: Leukemia
4 Locations available
- Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Conditions: Leukaemia, Lymphocytic, Chronic
11 Locations available
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
164 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) - Chronic Lymphocytic Leukemia (CLL) - Non-Hodgkins Lymphoma (NHL) - Cutaneous T Cell Lymphoma (CTCL) - Adult T Cell Lymphoma (ATL)
1 Location available
- A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocy
Conditions: Monoclonal B-Cell Lymphocytosis
1 Location available
- A Study of the Effect of Vinca Alkaloids on JNK Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL)
1 Location available
- A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL)
4 Locations available
|